duloxetine hydrochloride has been researched along with Diabetic Retinopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelghany, AA; Arafa, EA; Bahr, HI; Barakat, BM; Fawzy, MS; Galhom, RA | 1 |
1 other study(ies) available for duloxetine hydrochloride and Diabetic Retinopathy
| Article | Year |
|---|---|
Duloxetine protects against experimental diabetic retinopathy in mice through retinal GFAP downregulation and modulation of neurotrophic factors.
Topics: Analysis of Variance; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Down-Regulation; Duloxetine Hydrochloride; Glial Fibrillary Acidic Protein; Male; Mice; Nerve Growth Factors; Neuroprotective Agents; Retina | 2019 |